Higher-for-longer is turning financials from dead money into the market's overlooked hedge
If the Fed stays more hawkish than equity investors want to admit, financials look like a cleaner macro expression than hiding in pricey defensives or reflexively buying every tech dip. Banks and insurers are not a recession-proof all-clear, but in a sticky-rate regime they offer cheaper cash flows, less duration risk, and a better chance to outperform by simply being less crowded.
The market is finally being forced to price a possibility it spent most of the year trying to ignore: rates may stay high for longer, and that changes what counts as defensive. In that world, financials stop looking like dead money and start looking like one of the few large sectors that can absorb a hawkish Fed without asking investors to pay up for distant growth. That does not mean buying banks and insurers is a bet on a booming economy. It means they are a more grounded way to own the consequences of sticky inflation and stubborn policy than chasing long-duration growth every time it wobbles.
The key point is not that financials are suddenly exciting. It is that they are useful. After the June 16-17 FOMC repricing, the tape told the story: a stronger dollar, pressure on crowded tech, and rotation toward sectors that do not need lower discount rates to justify their valuations. That is exactly where banks and insurers fit. Their earnings power is tied more to current rates, spreads, fee pools, and underwriting discipline than to heroic assumptions about cash flows five years out.
The valuation case matters because this is where the market still seems conflicted. Investors will happily pay up for anything branded as secular growth, but they remain skeptical of financials even when the numbers are plainly serviceable. Consider the spread:
Those are not distressed multiples. They are simply undemanding ones, especially for businesses that are still generating real profits. JPM at 15.97x earnings with a 20.7% net margin is not a deep-value oddity, but it is a far cleaner rate-sensitive holding than expensive defensives that already trade like bond proxies. BAC at 14.33x with an 18.1% net margin looks similar: not a screaming bargain, but hardly priced for perfection. If the macro debate is really about whether policy stays tighter than expected, that kind of setup is more compelling than paying premium multiples for sectors that need falling yields to re-rate.
The insurer side may be even more interesting because it strips out some of the credit anxiety that always hangs over banks. PGR and CB both trade near 12x earnings, but they are not low-quality placeholders. PGR is posting 16.3% revenue growth and 33.5% EPS growth, while CB combines a 12.21x P/E with an 18.5% net margin and a 10.1% YTD gain. That is the overlooked part of this trade: if investors want a higher-for-longer hedge, insurers may be the cleaner expression because they are less hostage to the same economic fears that make people hesitate on regional banks.
Yes, the bulls on tech would argue that a few hawkish days do not break the AI capex story, and they are right about that much. And yes, bank skeptics can point to capital-rule pressure and the risk that higher rates eventually become a growth problem rather than an earnings tailwind. But that counter misses the actual appeal here. Financials do not need to become the market’s new leadership cult to work; they only need to keep looking more durable than the crowded alternatives when rates stay sticky and investors realize they have overpaid for duration elsewhere.
That is also why we would not frame this as a blanket all-clear on the economy or on every corner of the sector. GS at 18.63x earnings is not the same trade as AIG at 9.35x, and KRE is not interchangeable with money-center banks or P&C insurers. There are real differences in regulatory exposure, funding sensitivity, and business mix. But the broad point still holds: when the market is repricing the Fed hawkishly, the better question is not whether financials are perfect. It is whether they are a more rational place to hide than expensive defensives or every dip in long-duration growth. On that comparison, the answer is increasingly yes.
The relative performance already hints that investors are testing that idea. GS is up 11.5% YTD, CB is up 10.1%, and PGR is up 5.8%, while even the laggards are not being valued as if their earnings streams are broken. AIG is the clearest example of the opportunity and the skepticism coexisting in one stock: a 9.35x P/E and 62.1% EPS growth, yet still down 10.3% YTD. That is what overlooked looks like. Not universally loved, not clean enough for momentum tourists, but increasingly relevant when the macro regime shifts away from easy money assumptions.
The contrarian case for financials is not that they are cheap for no reason. It is that the reason may already be more than priced in, while the market is still underestimating how awkward higher-for-longer is for everything else. If the Fed remains more hawkish than equity investors want to admit, banks and insurers can outperform simply by being less duration-sensitive, less crowded, and more anchored in current cash generation.
What would change our mind? A sharp deterioration in credit, a regulatory hit that meaningfully crimps returns, or a fast collapse in yields that restores the old long-duration playbook. Short of that, we think financials are graduating from dead money to useful hedge — and in this market, useful may be enough.
Our take, not advice. This is opinion commentary — informational only, not personalized investment recommendations. Markets carry risk. Do your own research and consider your own situation before any trade.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
